Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11426362 Oral cannabinoid formulations

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
February 15, 2018
0
Date of Patent
August 30, 2022
0
Patent Application Number
16486750
0
Patent Citations
‌
US Patent 10137095 Use of cannabinoids in the treatment of epilepsy
0
‌
US Patent 10111840 Use of cannabinoids in the treatment of epilepsy
‌
US Patent 10092525 Use of cannabinoids in the treatment of epilepsy
Patent Citations Received
‌
US Patent 12102619 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
0
‌
US Patent 11701330 Use of cannabinoids in the treatment of epilepsy
0
‌
US Patent 11766411 Use of cannabinoids in the treatment of epilepsy
‌
US Patent 11865102 Cannabidiol preparations and its uses
0
‌
US Patent 11963937 Use of cannabinoids in the treatment of epilepsy
0
‌
US Patent 11633369 Use of cannabinoids in the treatment of epilepsy
0
Patent Inventor Names
Jitinder Wilkhu
0
Stephen Wright
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11426362
0
Patent Primary Examiner
‌
Shengjun Wang
0
CPC Code
‌
A61K 9/107
0
‌
A61K 31/352
0
‌
A61K 9/1075
0
‌
A61K 9/0053
0

Find more entities like US Patent 11426362 Oral cannabinoid formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.